Genmab

	20/5 09:52 af E L	JNJ press release - Updated Amivantamab and Lazertinib Combination Data Demonstrate Durable Responses and Clinical Activity for Osimertinib-Relapsed Patients with EGFR-Mutated Non-Small Cell Lung Cancer - (link)
	20/5 09:47 af Hamming	Lidt konkurrence til Genmab og Biontech (link)
	20/5 09:45 af Bulder	Bemærker lige at teclis heller ikke har CRS over grade 2. 30% CR som monoterapi er stærkt. Vi er i 6. linje i gns.
	20/5 09:38 af E L	any thoughts on Amivantamab in combination with lazertinib for the treatment of osimertinib-relapsed? (link) not sure if this is the same sub-group as previously presented?
	20/5 08:56 af E L	I didn't realise JNJ are also trying Amivantamab subcutaneous WITHOUT hyaluronidase , so just SC administration of a low concentration (50 mg/mL) formulation of amivantamab alone. Let's hope that works well enough. (link)
	20/5 08:33 af E L	ASCO : Updated results of a phase 1, first-in-human study of talquetamab - (link)
	20/5 08:32 af E L	ASCO : Updated phase 1 results of teclistamab - (link)
	20/5 08:26 af JørgenVarnæs	Bulder 13.56 tusind tak for info
	20/5 08:21 af Solsen	Bemærkningen “mostly manageable” er da interessant, som også bulder fremhæver 23:35
	20/5 08:09 af Helge Larsen/PI-redaktør	Er svagheden i biotekaktier forbigående? Bryder Novo Nordisk ud af sit kursinterval? Er inflationsfaren reel – eller er det et buzzword? Samt verden ifølge elonmusk & tsla. Lyt med i afsnit 66 af Investeringspodcasten med PerNordnet ogHelgeLarsen. (link) .
	20/5 07:17 af Helge Larsen/PI-redaktør	Torsdagens danske avisuddrag med Bitcoin, Salling Group og Rockwool: (link)
	20/5 06:53 af Helge Larsen/PI-redaktør	Genmab Announces Abstracts Evaluating Products in Pipeline, Portfolio to be Presented at American Society of Clinical Oncology : (link)
	20/5 06:52 af Helge Larsen/PI-redaktør	God morgen. :-)
	20/5 06:52 af Helge Larsen/PI-redaktør	Genmab vil præsentere data til kommende konferencer - GENT (link)
	19/5 23:50 af Bulder	Responser synes jeg er svært at udlede, men epco nævner 55% CR og glofi nævner 57,1% CMR i dlbcl. Altså næsten det samme. Med alle forbehold.
	19/5 23:46 af peter12	Media release (link)
	19/5 23:35 af Bulder	Well, glofi har 3 pts ud af 52 med CRS grade 3. Epco har ingen over grade 2. Glofi: CRS was mostly(!) manageable.
	19/5 17:21 af E L	a much better way to spend your time lol, enjoy!
	19/5 17:19 af Helge Larsen/PI-redaktør	E L I play football tonight with the young people in the club. Must therefore, as usual, go to bed early and get up late tomorrow. :-D
	19/5 17:16 af Darvin	Rigth EL 17.10 65% increase compared to april 2020 and 46,5% increase compared to først 4 months 2020. Excellent
	19/5 17:12 af E L	good luck Helge, looking forward to the summaries tomorrow morning ;-)
	19/5 17:11 af GeorgeBest	Thanks E L & Bulder
	19/5 17:11 af Bulder	asco abstracts are released at 23.00 tonight
	19/5 17:10 af E L	didn't check but could be an all time high % change over last year...

	19/5 17:09 af E L	yes, last year apr and may was slow, wasn't it, great % rise over last year this month
	19/5 17:06 af Darvin	Ikke - 6 men +6
	19/5 17:06 af E L	and by the way that eha data was very good, and will get more attention at ASCO
	19/5 17:05 af Darvin	Tak Helge. Mindre rettelse - 6% stigning ift marts, da der var en arbejdsdag mindre. Fortsat rigtig fint. Væsentligt bedre 4 mdr i 21 end de første 4 i 20
	19/5 17:04 af E L	i know, but the EHA and ASCO abstract had to be sent in around the same time, so the data can not be (much) different i think. They may elaborate with a bit of an update again in June, during the presentation though?
	19/5 17:00 af GeorgeBest	Okay E L. I just had this comment in mind from Jan, and it was related to ASCO: „ Let us start with our own product candidates. There will be an important presentation on epco data from the initial Phase I/II study. This presentation will highlight the promise and success of our DuoBody platform..“
	19/5 16:59 af E L	thanks Helge; solid number; next month over >300
	19/5 16:57 af E L	But I think we have see all the epco data we will get in the EHA abstract this week tbh
	19/5 16:57 af Helge Larsen/PI-redaktør	Sorry. I've been busy all day with podcasts and video production. Darzalex April was $ 298M. Increase of just over 10% as there were 2 working days less compared to March. :-)
	19/5 16:57 af E L	I am sure Helge will categorise them appropriately ;-)
	19/5 16:55 af GeorgeBest	Dara abstracts are boring ;-) I am more interested in the next winner...
	19/5 16:50 af E L	:-D Helge is absent today because he needs to sleep whole day; he will need the whole night to prepare summaries for us for tomorrow morning ;-) 60 Dara abstracts lol
	19/5 16:46 af GeorgeBest	E L, when do you have the ASCO abstracts for us? ;-)
	19/5 15:13 af E L	@_Hubrecht & @Genmab received the Galien Excellence COVID-19 Award for the STRIP-1 SARS-CoV-2 testing robot (link)
	19/5 15:01 af Bulder	Stadig ingen SH-tal?
	19/5 14:55 af E L	;-)
	19/5 14:52 af Bulder	Yes, Blenrep, once a threat, now a partner. They all want to make friends with dara.
	19/5 14:42 af E L	it seems they forgot epco at EHA ;)
	19/5 14:42 af E L	AbbVie to Showcase Breadth of Oncology Portfolio and Pipeline at the 2021 ASCO (link)
	19/5 14:28 af E L	lol, new trial: Blenrep in combi with Dara - (link)
	19/5 14:22 af E L	Gilead’s Magrolimab is an Investigational Anti-CD47 Monoclonal Antibody- in new trial with a.o. Dara here for MM (link) (just after Sukkeralf asked Jan about the Blink cooperation...)
	19/5 13:58 af Bulder	Det har i øvrigt vist sig at give færre bivirkninger end IV, selv om denne indgives over mange timer.
	19/5 13:56 af Bulder	JV 11.35: Kesimpta gives med autoinjektor med 20 mg. Dara Faspro er 1800 mg. Det gør en forskel, som nødvendiggør hyaluronidase, som får dara til at ligge i et reservoir under huden, så det optages langsomt.
	19/5 12:40 af Bulder	Ingen tvivl om at det afgørende spm ved hexa38 er tåleligheden. Når man i sin tid var skeptiske ved dara, skyldes det at cd38 findes overalt i kroppen. Så med et endnu mere potent stof, kan det måske volde problemer.
	19/5 12:31 af Bulder	Nogen SH-tal?
	19/5 11:44 af JørgenVarnæs	Nice! Thx EL